The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the GSM Fund, startups are often financed by Technology Partners, Morgenthaler Ventures, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Technology Partners, Morgenthaler Ventures, Kleiner Perkins. In the next rounds fund is usually obtained by Technology Partners, Sailing Capital, Morgenthaler Ventures.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Navigation. Among the various public portfolio startups of the fund, we may underline Elcelyx Therapeutics
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| Apodaca Investments | California, Huntington Beach, United States |
| Astra Ventura | Indonesia, Jakarta, Jakarta Raya |
| Banco Itau | Brazil, São Paulo, Sao Paulo |
| DeNA | Chiyoda, Japan |
| International Vitamin | Freehold, New Jersey, United States |
| iRobot Corp | - |
| KI Capital GmbH | - |
| Milestone | China, Shanghai |
| perceptiveEQUITY | - |
| XL Africa | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Elcelyx Therapeutics | $24M | 20 Feb 2014 | San Diego, California, United States | ||
Webraska | $11M | 31 Jan 2000 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Elcelyx Therapeutics | $24M | 20 Feb 2014 | San Diego, California, United States | ||
Webraska | $11M | 31 Jan 2000 | Ile-de-France |
